Inotiv, Inc. (NOTV) Reports Q4 Loss of $9.54/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Inotiv, Inc. Announces Fourth Quarter and Full Year Fiscal 2022 Financial Results
January 10, 2023 4:05 PM ESTProvides Select First Quarter and Full Year Fiscal 2023 Financial Guidance
WEST LAFAYETTE, Ind., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the Company, We, Our or Inotiv), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced financial results for the three months (Q4 FY 2022) and twelve months (FY 2022) ended September 30, 2022.
Financial Highlights
FY 2022 Highlights
Revenue grew to... More